Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair

References

• Boulter L, Govaere O, Bird TG, et al. Macrophage-derived Wnt opposes notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012;18:572–579.
   PubMed Web of Science ®Google Scholar
• Manzella A, Ohtomo K, Monzawa S, et al. Schistosomiasis of the liver. Abdom Imaging. 2008;33(2):144150.
   Google Scholar
• Dessein AJ, Hillaire D, Elwali NEMA, et al. Severe hepatic fibrosis in schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-γ receptor gene. Am J Hum Genet. 1999;65(3):709–721.
   PubMed Web of Science ®Google Scholar
• Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102(3):538–549.
   PubMed Web of Science ®Google Scholar
• Lorenzini S, Bird TG, Boulter L, et al. Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut. 2010;59:645–654.
   PubMed Web of Science ®Google Scholar
• Issa R, Zhou X, Constandinou CM, et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology. 2004;126(7):1795–1808.
   PubMed Web of Science ®Google Scholar
• Holstein TW. The evolution of the wnt pathway. Cold Spring Harb Perspect Biol. 2012
   PubMed Web of Science ®Google Scholar
• Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461–1473.
   Web of Science ®Google Scholar
• Grumolato L, Liu G, Mong P, et al. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 2010;24:2517–2530.
   Web of Science ®Google Scholar
• Niida A, Hiroko T, Kasai M, et al. DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway. Oncogene. 2004;23:8520–8526.
   PubMed Web of Science ®Google Scholar
• Huch M, Gehart H, Van Boxtel R, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015;160:299–312.
   Web of Science ®Google Scholar
• Barker N, Van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007.
   PubMed Web of Science ®Google Scholar
• Snippert HJ, Haegebarth A, Kasper M, et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science. 2010;327:1385–1389.
   PubMed Web of Science ®Google Scholar
• Peng WC, De Lau W, Madoori PK, et al. Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling. PLoS One. 2013;8:e83110.
   Web of Science ®Google Scholar
• Steinhart Z, Pavlovic Z, Chandrashekhar M, et al. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors. Nat Med. 2017;23 (1):60–68.
   Web of Science ®Google Scholar
• Burke ZD, Reed KR, Phesse TJ, et al. Liver zonation occurs through a β-catenin-dependent, c-Myc-independent mechanism. Gastroenterology. 2009;136 (7).
   Google Scholar
• Benhamouche S, Decaens T, Godard C, et al. Apc tumor suppressor gene is the “Zonation-Keeper” of mouse liver. Dev Cell. 2006;10:759–770.
   PubMed Web of Science ®Google Scholar
• Halpern KB, Shenhav R, Matcovitch-Natan O, et al. Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature. 2017;542(7641):352–356.
   Web of Science ®Google Scholar
• Rocha AS, Vidal V, Mertz M, et al. The angiocrine factor rspondin3 is a key determinant of liver zonation. Cell Rep. 2015;13:1757–1764.
   PubMed Web of Science ®Google Scholar
• Planas-Paz L, Orsini V, Boulter L, et al. The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nat Cell Bio. 2016;18:467–479.
   PubMed Web of Science ®Google Scholar
• Torban E, Wang HJ, Groulx N, et al. Independent mutations in mouse Vangl2 that cause neural tube defects in looptail mice impair interaction with members of the dishevelled family. J Biol Chem. 2004;279:52703–52713.
   PubMed Web of Science ®Google Scholar
• Nishimura T, Honda H, Takeichi M. Planar cell polarity links axes of spatial dynamics in neural-tube closure. Cell. 2012;149:1084–1097.
   PubMed Web of Science ®Google Scholar
• Escobedo N, Contreras O, Muñoz R, et al. Syndecan 4 interacts genetically with Vangl2 to regulate neural tube closure and planar cell polarity. Dev. 2013;140:3008–3017.
   PubMed Web of Science ®Google Scholar
• Chacon-Heszele MF, Ren D, Reynolds AB, et al. Regulation of cochlear convergent extension by the vertebrate planar cell polarity pathway is dependent on p120-catenin. Development. 2012;139:968–978. [Internet]. Available from: http://dev.biologists.org/cgi/doi/10.1242/dev.065326
   PubMed Web of Science ®Google Scholar
• Yates LL, Papakrivopoulou J, Long DA, et al. The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation. Hum Mol Genet. 2010;19:4663–4676.
   PubMed Web of Science ®Google Scholar
• Yates LL, Schnatwinkel C, Murdoch JN, et al. The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis. Hum Mol Genet. 2010;19:2251–2267.
   PubMed Web of Science ®Google Scholar
• Poobalasingam T, Yates LL, Walker SA, et al. Heterozygous Vangl2Looptail mice reveal novel roles for the planar cell polarity pathway in adult lung homeostasis and repair. Dis Model Mech. 2017;10:409–423. [Internet]. Available from: http://dmm.biologists.org/lookup/doi/10.1242/dmm.028175%0Ahttp://www.ncbi.nlm.nih.gov/pubmed/28237967%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5399569
   PubMed Web of Science ®Google Scholar
• Ségalen M, Johnston CA, Martin CA, et al. The Fz-Dsh planar cell polarity pathway induces oriented cell division via Mud/NuMA in drosophila and zebrafish. Dev Cell. 2010;19:740–752.
   PubMed Web of Science ®Google Scholar
• Xu B, Washington AM, Domeniconi RF, et al. Protein tyrosine kinase 7 is essential for tubular morphogenesis of the wolffian duct. Dev Biol. 2016;412:219–233.
   PubMed Web of Science ®Google Scholar
• Yamada M, Udagawa J, Matsumoto A, et al. Ror2 is required for midgut elongation during mouse development. Dev Dyn. 2010;239:941–953.
   Web of Science ®Google Scholar
• Qian D, Jones C, Rzadzinska A, et al. Wnt5a functions in planar cell polarity regulation in mice. Dev Biol. 2007;306:121–133.
   PubMed Web of Science ®Google Scholar
• Shafer B, Onishi K, Lo C, et al. Vangl2 promotes Wnt/planar cell polarity-like signaling by antagonizing Dvl1-mediated feedback inhibition in growth cone guidance. Dev Cell. 2011;20:177–191.
   PubMed Web of Science ®Google Scholar
• Hayes MN, McCarthy K, Jin A, et al. Vangl2/RhoA signaling pathway regulates stem cell self-renewal programs and growth in rhabdomyosarcoma. Cell Stem Cell. 2018;22:414–427.e6.
   PubMed Web of Science ®Google Scholar
• Puvirajesinghe TM, Bertucci F, Jain A, et al. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer. Nat Commun. 2016;7:10318.
   PubMed Web of Science ®Google Scholar
• Cui S, Capecci LM, Matthews RP. Disruption of planar cell polarity activity leads to developmental biliary defects. Dev Biol. 2011;351:229–241.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125–172.
   PubMed Web of Science ®Google Scholar
• Bayle J, Fitch J, Jacobsen K, et al. Increased expression of Wnt2 and SFRP4 in tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis. J Invest Dermatol. 2008;128:871–881.
   PubMed Web of Science ®Google Scholar
• Liu L, Carron B, Yee HT, et al. Wnt pathway in pulmonary fibrosis in the bleomycin mouse model. J Environ Pathol Toxicol Oncol. 2009;28:99–108.
   PubMed Web of Science ®Google Scholar
• He W, Dai C, Li Y, et al. Wnt/β-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009;20:765–776.
   Web of Science ®Google Scholar
• He W, Tan RJ, Li Y, et al. Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD. J Am Soc Nephrol. 2012;23:294–304.
   Web of Science ®Google Scholar
• Guo Y, Xiao L, Sun L, et al. Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 2012;61:337–346.
   PubMed Web of Science ®Google Scholar
• Carpino G, Nevi L, Overi D, et al. Peribiliary gland niche participates in biliary tree regeneration in mouse and in human primary sclerosing cholangitis. Hepatology. 2019. Available from: https://doi.org/10.1002/hep.30871
   Web of Science ®Google Scholar
• Carpino G, Cardinale V, Folseraas T, et al. Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis. Am J Pathol. 2018;188:627–639.
   PubMed Web of Science ®Google Scholar
• Carpino G, Nobili V, Renzi A, et al. Macrophage activation in pediatric nonalcoholic fatty liver disease (NAFLD) correlates with hepatic progenitor cell response via Wnt3a pathway. PLoS One. 2016;11:e0157246.
   Web of Science ®Google Scholar
• Saadi-Kheddouci S, Berrebi D, Romagnolo B, et al. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene. Oncogene. 2001;20:5972–5981.
   PubMed Web of Science ®Google Scholar
• Wei J, Melichian D, Komura K, et al. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma? Arthritis Rheum. 2011;63:1707–1717.
   PubMedGoogle Scholar
• Lam AP, Herazo-Maya JD, Sennello JA, et al. Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2014;190:185–195.
   PubMed Web of Science ®Google Scholar
• Wang S, Song K, Srivastava R, et al. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a. Faseb J. 2015;29:3436–3445.
   PubMed Web of Science ®Google Scholar
• Surendran K, Schiavi S, Hruska KA. Wnt-dependent β-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol. 2005;16:2373–2384.
   PubMed Web of Science ®Google Scholar
• Brack AS, Conboy MJ, Roy S, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007;317:807–810.
   PubMed Web of Science ®Google Scholar
• Trensz F, Haroun S, Cloutier A, et al. A muscle resident cell population promotes fibrosis in hindlimb skeletal muscles of mdx mice through the Wnt canonical pathway. Am J Physiol - Cell Physiol. 2010;299:C939-C947.
   PubMed Web of Science ®Google Scholar
• Myung SJ, Yoon JH, Gwak GY, et al. Wnt signaling enhances the activation and survival of human hepatic stellate cells. FEBS Lett. 2007;581:2954–2958.
   PubMed Web of Science ®Google Scholar
• Hao HX, Xie Y, Zhang Y, et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature. 2012;485:195–200.
   PubMed Web of Science ®Google Scholar
• Jiang F, Parsons CJ, Stefanovic B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol. 2006;45:401–409.
   PubMed Web of Science ®Google Scholar
• Cheng JH, She H, Han YP, et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2008;294:G39–49.
   PubMed Web of Science ®Google Scholar
• Xiong WJ, Hu LJ, Jian YC, et al. Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays. World J Gastroenterol. 2012;18:1745–1752.
   PubMed Web of Science ®Google Scholar
• Zeng G, Awan F, Otruba W, et al. Wnt’er in liver: expression of Wnt and frizzled genes in mouse. Hepatology. 2007;45:195–204.
   Web of Science ®Google Scholar
• Okabe H, Yang J, Sylakowski K, et al. Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice. Hepatology. 2016;64:1652–1666.
   PubMed Web of Science ®Google Scholar
• Jiang A, Okabe H, Popovic B, et al. Loss of Wnt secretion by macrophages promotes hepatobiliary injury after administration of 3,5-diethoxycarbonyl-1, 4-dihydrocollidine diet. Am J Pathol. 2019;189:590–603.
   Web of Science ®Google Scholar
• Hu M, Kurobe M, Jeong YJ, et al. Wnt/β-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology. 2007;133:1579–1591.e1.
   Web of Science ®Google Scholar
• Pepe-Mooney BJ, Dill MT, Alemany A, et al. Single-cell analysis of the liver epithelium reveals dynamic heterogeneity and an essential role for YAP in homeostasis and regeneration. Cell Stem Cell. 2019;25:23–38.e8.
   PubMed Web of Science ®Google Scholar
• Planas-Paz L, Sun T, Pikiolek M, et al. YAP, but not RSPO-LGR4/5, signaling in biliary epithelial cells promotes a ductular reaction in response to liver injury. Cell Stem Cell. 2019;25:39–53.e10.
   PubMed Web of Science ®Google Scholar
• Sampaziotis F, Justin AW, Tysoe OC, et al. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids. Nat Med. 2017;23:954–963.
   PubMed Web of Science ®Google Scholar
• Loilome W, Bungkanjana P, Techasen A, et al. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. Tumor Biol. 2014;35:5357–5367.
   PubMedGoogle Scholar
• Irvine KM, Clouston AD, Gadd VL, et al. Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury. Fibrogenes Tissue Repair. 2015;8 (19).
   Web of Science ®Google Scholar
• Williams BB, Mundell NA, Dunlap JA, et al. The planar cell polarity protein VANGL2 coordinates remodeling of the extracellular matrix. Commun Integr Biol. 2012;5:325–328.
   PubMedGoogle Scholar
• Jessen TN, Jessen JR. VANGL2 interacts with integrin αv to regulate matrix metalloproteinase activity and cell adhesion to the extracellular matrix. Exp Cell Res. 2017;361:265–276.
   PubMed Web of Science ®Google Scholar
• Williams BB, Cantrell VA, Mundell NA, et al. VANGL2 regulates membrane trafficking of MMP14 to control cell polarity and migration. J Cell Sci. 2012;125:2141–2147. [Internet]. DOI:10.1242/jcs.097964
   PubMed Web of Science ®Google Scholar
• Li Z, Takino T, Endo Y, et al. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis. Cancer Sci. 2017;108:347–353.
   Web of Science ®Google Scholar
• Wilson DH, Mellin RP, Younger NT, et al. Non-canonical Wnt signalling initiates scarring in biliary disease. bioRxiv. [Internet]. 2018;276196. Available from: http://biorxiv.org/content/early/2018/03/19/276196.abstract
   Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325–338.
   PubMed Web of Science ®Google Scholar
• Xu F, Liu C, Zhou D, et al. TGF-β/SMAD Pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016;64:157–167.
   Web of Science ®Google Scholar
• Walton KL, Johnson KE, Harrison CA. Targeting TGF-β mediated SMAD signaling for the prevention of fibrosis. Front Pharmacol. 2017;8:461.
   PubMed Web of Science ®Google Scholar
• Yanagita M. Inhibitors/antagonists of TGF-beta system in kidney fibrosis. Nephrol Dial Transpl. 2012;27:3686–3691.
   PubMed Web of Science ®Google Scholar
• Wei Y, Kim TJ, Peng DH, et al. Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis. J Clin Invest. 2017;127:3675–3688.
   PubMed Web of Science ®Google Scholar
• Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF-β signaling pathway in hepatic fibrosis. Liver Int. 2006;26:8–22.
   PubMed Web of Science ®Google Scholar
• Giannelli G, Mikulits W, Dooley S, et al. The rationale for targeting TGF-β in chronic liver diseases. Eur J Clin Invest. 2016;46:349–361.
   PubMed Web of Science ®Google Scholar
• Lam AP, Gottardi CJ. beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol. 2011;23:562–567.
   PubMed Web of Science ®Google Scholar
• Cheon SS, Wei Q, Gurung A, et al. Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing. Faseb J. 2006. 20 (6) 692–701.
   PubMed Web of Science ®Google Scholar
• Sato M. Upregulation of the Wnt/β-catenin pathway induced by transforming growth factor-β in hypertrophic scars and keloids. Acta Derm Venereol. 2006;86:300–307.
   PubMed Web of Science ®Google Scholar
• Akhmetshina A, Palumbo K, Dees C, et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun. 2012;3:735.
   PubMed Web of Science ®Google Scholar
• Amini Nik S, Ebrahim RP, Van Dam K, et al. TGF-beta modulates beta-Catenin stability and signaling in mesenchymal proliferations. Exp Cell Res. 2007;313:2887–2895.
   PubMed Web of Science ®Google Scholar
• Eger A, Stockinger A, Park J, et al. β-catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene. 2004;23:2672–2680.
   PubMed Web of Science ®Google Scholar
• Kim KK, Wei Y, Szekeres C, et al. Epithelial cell alpha3beta1 integrin links beta-catenin and smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest. 2009;119:213–224.
   PubMed Web of Science ®Google Scholar
• Dewidar B, Soukupova J, Fabregat I, et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis: updated. Curr Pathobiol Rep. 2015;3:291–305.
   Google Scholar
• Vallee A, Lecarpentier Y, Guillevin R, et al. Interactions between TGF-beta1, canonical WNT/beta-catenin pathway and PPAR gamma in radiation-induced fibrosis. Oncotarget. 2017;8:90579–90604.
   PubMedGoogle Scholar
• Wei J, Ghosh AK, Sargent JL, et al. PPAR? downregulation by tgf in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis. PLoS One. 2010;5:e13778.
   Web of Science ®Google Scholar
• Miyahara T, Schrum L, Rippe R, et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem. 2000;275:35715–35722.
   Google Scholar
• Kawaguchi K, Sakaida I, Tsuchiya M, et al. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun. 2004;315:187–195.
   PubMed Web of Science ®Google Scholar
• Uto H, Nakanishi C, Ido A, et al. The peroxisome proliferator-activated receptor-γ agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Hepatol Res. 2005;32(4):235–242.
   Web of Science ®Google Scholar
• Gustafson B, Eliasson B, Smith U. Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: A link with osteogenesis. Diabetologia. 2010;53:536–540.
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog Neurobiol. 2001;61(4):391–426.
   PubMed Web of Science ®Google Scholar
• Ross SE, Erickson RL, Hemati N, et al. Glycogen synthase kinase 3 is an insulin-regulated C/EBPα kinase. Mol Cell Biol. 1999;19:8433–8441.
   PubMed Web of Science ®Google Scholar
• Zhu NL, Asahina K, Wang J, et al. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration. J Biol Chem. 2012;287:10355–10367.
   PubMed Web of Science ®Google Scholar
• Zhu D, He X, Duan Y, et al. Expression of microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in mouse livers infected with schistosoma japonicum. Parasites Vectors. 2014;7:148.
   Web of Science ®Google Scholar
• Wang YZ, Zhang W, Wang YH, et al. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a. J Biochem. 2019;165(4):361–367.
   Web of Science ®Google Scholar
• Yu F, Lu Z, Huang K, et al. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis. Oncotarget. 2016;7(1):81–93.
   Google Scholar
• Lv X, Li J, Hu Y, et al. Overexpression of miR-27b-3p targeting Wnt3a regulates the signaling pathway of Wnt/β-catenin and attenuates atrial fibrosis in rats with atrial fibrillation. Oxid Med Cell Longev. 2019;2019:1–13.
   Google Scholar
• Wang X, Xu K, Yang XY, et al. Upregulated miR-29c suppresses silica-induced lung fibrosis through the Wnt/β-catenin pathway in mice. Hum Exp Toxicol. 2018;37:944–952.
   Web of Science ®Google Scholar
• Yanagida A, Iwaisako K, Hatano E, et al. Downregulation of the Wnt antagonist Dkk2 links the loss of sept4 and myofibroblastic transformation of hepatic stellate cells. Biochim Biophys Acta. 2011;1812:1403–1411.
   PubMed Web of Science ®Google Scholar
• Sansom OJ, Meniel VS, Muncan V, et al. Myc deletion rescues apc deficiency in the small intestine. Nature. 2007;446:676–679.
   PubMed Web of Science ®Google Scholar
• Monga SP. Beta-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology. [Internet]. 2015;148:1294–1310. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25747274
   PubMed Web of Science ®Google Scholar
• Kahn M. Can we safely target the WNT pathway? NatRev Drug Discov. 2014;13(7):513–532.
   Web of Science ®Google Scholar
• Kinzel B, Pikiolek M, Orsini V, et al. Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. Dev Biol. 2014;390:181–190.
   PubMed Web of Science ®Google Scholar
• Acebron SP, Karaulanov E, Berger BS, et al. Mitotic Wnt signaling promotes protein stabilization and regulates cell size. Mol Cell. 2014;54:663–674.
   PubMed Web of Science ®Google Scholar
• Akcora BÖ, Storm G, Bansal R. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12. Biochim Biophys Acta - Mol Basis Dis. 2018;1864:804–818.
   PubMed Web of Science ®Google Scholar
• Tokunaga Y, Osawa Y, Ohtsuki T, et al. Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model. Sci Rep. 2017;7(1):325.
   Web of Science ®Google Scholar
• Nile AH, De Sousa EMF, Mukund S, et al. A selective peptide inhibitor of frizzled 7 receptors disrupts intestinal stem cells article. Nat Chem Biol. 2018;14(6):582–590
   Web of Science ®Google Scholar
• Pavlovic Z, Adams JJ, Blazer LL, et al. A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties. MAbs. 2018;10:1157–1167.
   PubMed Web of Science ®Google Scholar
• Gong Y, Bourhis E, Chiu C, et al. Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies. PLoS One. 2010;5:e12682.
   Web of Science ®Google Scholar
• Pinho AV, Van Bulck M, Chantrill L, et al. ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. Nat Commun. 2018;9.
   PubMed Web of Science ®Google Scholar
• Takada R, Satomi Y, Kurata T, et al. Monounsaturated fatty acid modification of wnt protein: its role in wnt secretion. Dev Cell. 2006;11:791–801.
   PubMed Web of Science ®Google Scholar
• Saha S, Aranda E, Hayakawa Y, et al. Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury. Nat Commun. 2016;7:13096.
   Web of Science ®Google Scholar
• Funck-Brentano T, Nilsson KH, Brommage R, et al. Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice. J Endocrinol. 2018;238:13–23.
   PubMed Web of Science ®Google Scholar
• Madan B, McDonald MJ, Foxa GE, et al. Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy. Bone Res. 2018;6(17).
   Web of Science ®Google Scholar
• Emami KH, Nguyen C, Ma H, et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A. 2004;101:12682–12687.
   PubMed Web of Science ®Google Scholar
• Boulter L, Guest RV, Kendall TJ, et al. WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. J Clin Invest. 2015;125:1269–1285.
   PubMed Web of Science ®Google Scholar
• Ma H, Nguyen C, Lee KS, et al. Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression. Oncogene. 2005;24:3619–3631.
   Web of Science ®Google Scholar
• Harb J, Lin PJ, Hao J. Recent development of Wnt signaling pathway inhibitors for cancer therapeutics. Curr Oncol Rep. [Internet]. 2019;21:12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30715618
   PubMed Web of Science ®Google Scholar
• Al-Dali AM, Weiher H, Schmidt-Wolf IGH. Utilizing ethacrynic acid and ciclopirox olamine in liver cancer. Oncol Lett. 2018;16(5).
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang L, Hu C, et al. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells. Int J Oncol. 2016;48:1175–1186.
   Web of Science ®Google Scholar
• Ren Y, Tao J, Jiang Z, et al. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway. Life Sci. 2018;209:267–273.
   Web of Science ®Google Scholar
• Fako V, Yu Z, Henrich CJ, et al. Inhibition of wnt/β-catenin signaling in hepatocellular carcinoma by an antipsychotic drug pimozide. Int J Biol Sci. 2016;12:768–775.
   PubMed Web of Science ®Google Scholar
• Boyapally R, Pulivendala G, Bale S, et al. Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt/β-catenin signaling: A drug repurposing study. Life Sci. 2019;220:8–20.
   PubMed Web of Science ®Google Scholar
• Pellicoro A, Ramachandran P, Iredale JP, et al. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181–194.
   PubMed Web of Science ®Google Scholar
• Jung Y, Brown KD, Witek RP, et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology. 2008;134:1532–1543.e3.
   PubMed Web of Science ®Google Scholar
• Ramachandran P, Henderson NC. Antifibrotics in chronic liver disease: tractable targets and translational challenges. Lancet Gastroenterol Hepatol. 2016;1:328–340.
   PubMed Web of Science ®Google Scholar
• Tojo M, Hamashima Y, Hanyu A, et al. The ALK-5 inhibitor A-83-01 inhibits smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-β. Cancer Sci. 2005;96:791–800.
   PubMed Web of Science ®Google Scholar
• Van Es JH, Van Gijn ME, Riccio O, et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005;435:959–963.
   PubMed Web of Science ®Google Scholar
• Flanagan DJ, Barker N, Di Costanzo NS, et al. Frizzled-7 is required for Wnt signaling in gastric tumors with and without APC mutations. Cancer Res. 2019;79:970–981.
   Web of Science ®Google Scholar